Patents Assigned to E.R.D.E.-AAK-DIAGNOSTIK GMBH - Justia Patents Search

Patents Assigned to E.R.D.E.-AAK-DIAGNOSTIK GMBH

Agonistic autoantibodies to the alpha1-adrenergic receptor and the beta2-adrenergic receptor in Alzheimer's and vascular dementia

Patent number: 9708372

Abstract: The invention relates to means for detecting, binding, removing and/or neutralizing agonistic antibodies associated with dementia, preferably Alzheimer's disease or vascular dementia.

Type: Grant

Filed: June 24, 2015

Date of Patent: July 18, 2017

Assignees: E.R.D.E.-AAK-DIAGNOSTIK GMBH, MAX-DEL-BRUCK-CENTRUM FÜR MOLEKULARE MEDIZIN

Inventors: Marion Bimmler, Peter Karczewski, Petra Hempel
AGONISTIC AUTOANTIBODIES TO THE ALPHA1-ADRENERGIC RECEPTOR AND THE BETA2-ADRENERGIC RECEPTOR IN ALZHEIMER'S AND VASCULAR DEMENTIA

Publication number: 20140199318

Abstract: The invention relates to means for detecting, binding, removing and/or neutralising agonistic antibodies associated with dementia, preferably Alzheimer's disease or vascular dementia.

Type: Application

Filed: July 13, 2012

Publication date: July 17, 2014

Applicants: MAX-DEL-BRUCK-CENTRUM FUR MOLEKULARE MEDIZIN, E.R.D.E.-AAK-DIAGNOSTIK GMBH

Inventors: Marion Bimmler, Peter Karczewski, Petra Hempel